Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- UBM.MI
- Price
- 0.81
- Stock movement down
- -0.00 (-0.49%)
- Company name
- Ulisse Biomed Spa
- Exchange
- (MI ,
- Currency
- EUR )
- Sector
- Healthcare >Biotechnology
- Market cap
- 20.56M
- Ent value
- 24.38M
- Price/Sales
- 15.27
- Price/Book
- 0.97
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 12.86%
- 1 year return
- 3.33%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-12-12
DIVIDENDS
UBM.MI does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 15.27 |
| Price to Book | 0.97 |
| EV to Sales | 18.10 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 25.51M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | -0.03 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.33K |
| Net receivables | 380.29K |
| Total current assets | 3.66M |
| Goodwill | 0.00 |
| Intangible assets | 18.36M |
| Property, plant and equipment | 0.00 |
| Total assets | 25.06M |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 1.70M |
| Total liabilities | 3.82M |
| Shareholder's equity | 21.24M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.81 |
| Daily high | 0.81 |
| Daily low | 0.79 |
| Daily Volume | 20K |
| All-time high | 6.29 |
| 1y analyst estimate | 1.29 |
| Beta | 0.80 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| UBM.MI | S&P500 | |
| Current price drop from All-time high | -87.19% | -1.08% |
| Highest price drop | -88.71% | -19.00% |
| Date of highest drop | 8 Apr 2025 | 8 Apr 2025 |
| Avg drop from high | -86.36% | -2.64% |
| Avg time to new high | - | 6 days |
| Max time to new high | 299 days | 89 days |
COMPANY DETAILS
Marketcap
20.56M
Marketcap category
Small-cap
Description
Ulisse Biomed S.p.A., a healthcare biotech company, develops, produces, and markets vitro diagnostic medical devices in Italy. The company through its Sagitta platform offers various tests, such as Ladymed/HPV Selfy for the detection of human papillomavirus (HPV); CoronaMelt, a diagnostic test for Sars- CoV-2; CoronaMelt Var, a diagnostic assay for the detection and genotyping of Sars-CoV-2 variants; and UlisseFaster, a reagent for the pre-treatment of biological samples. It provides various tests and reagents for sexually transmitted diseases and HPV. In addition, the company's platforms also comprise NanoHybrid, a platform to detect specific antibodies and protein analytes directly from serum or whole blood; and Aptavir platform to develop and produce synthetic nucleic acid molecules to limit the infectivity of pathogens. Ulisse Biomed S.p.A. was founded in 2015 and is based in Udine, Italy.
Employees
18
Website
Investor relations
-
SEC filings
CEO
Country
Italy
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found